Vinge has advised Axcel in connection with the investment in XPartners Samhällsbyggnad (“XPartners”), a sustainability-focused technical consulting group, specialising in infrastructure, public and commercial buildings as well as environmental services.

Following Axcel’s investment, the XPartners’ group consists of nine business units employing approximately 400 people across 30 offices in Sweden, generating approximately SEK 600 million in revenue. XPartners is the first investment of Axcel Fund VII.

For more information about the transaction, please see the client’s press release.

Vinge’s team consisted primarily of Christina Kokko, Karl Klackenberg, Carl Fredrik Wachtmeister, Egil Svensson and Elsa Strandberg (M&A), Daniel Prawitz (Construction), Daniel Melander Björner and Tove Hallbäck (Employment), Mikael Ståhl, Seyran Sahin, Karl-Gustaw Tobola and Ida Redander (Financing), Alexandra Tamm (Real Estate), Tove Tullberg and Julia Löfqvist (Compliance), Lisa Hörnqvist (GDPR), Trine Osen Bergqvist, Victoria Fredén and Alva Chambert (ECR) and Emy Rydén (project assistant).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025